Schonfeld Strategic Advisors LLC Nektar Therapeutics Transaction History

Schonfeld Strategic Advisors LLC

$14 Billion
Q1 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 535,800 shares of NKTR stock, worth $664,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

535,800

Previous 377,400 41.97%

Holding current value

$664,392

Previous $211,000 136.02%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.49 - $0.96 $77,616 - $152,064	158,400 Added 41.97%	535,800 $498,000
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.57 $108,444 - $147,174	258,200 Added 216.61%	377,400 $211,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.05 $44,472 - $91,560	87,200 Added 272.5%	119,200 $71,000
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $3,763 - $7,313	7,100 Added 28.51%	32,000 $18,000
Q1 2023 May 15, 2023	SELL	$0.64 - $3.15 $63,873 - $314,379	-99,803 Reduced 80.03%	24,900 $17,000

Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $178,059 - $375,415	-87,714 Reduced 41.29%	124,703 $281,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $408,019 - $689,875	134,217 Added 171.63%	212,417 $680,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $247,894 - $482,494	78,200 New	78,200 $297,000
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $169,769 - $559,913	-40,810 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $698,524 - $1.19 Million	-64,499 Reduced 61.25%	40,810 $552,000
Q3 2021 Nov 16, 2021	BUY	$13.07 - $18.84 $607,493 - $875,683	46,480 Added 79.01%	105,309 $1.89 Million
Q2 2021 Nov 16, 2021	SELL	$16.52 - $20.4 $5,930 - $7,323	-359 Reduced 0.61%	58,829 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $181,538 - $224,175	10,989 Added 22.8%	59,188 $1.02 Million
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $798,175 - $1.23 Million	48,199 New	48,199 $964,000
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $879,386 - $1.31 Million	-53,007 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $893,698 - $1.24 Million	53,007 New	53,007 $1.23 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $790,326 - $1.15 Million	-49,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $842,118 - $1.81 Million	49,800 New	49,800 $907,000
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $962,185 - $2.17 Million	-20,804 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $1.19 Million - $2.26 Million	20,804 New	20,804 $2.21 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Nektar Therapeutics Transaction History